Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

Mees Egeler; Julia Lai-Kwon; Renaud Tissier; Itske Fraterman; Anke Kuijpers; Winan Van Houdt; Sofie Wilgenhof; Aparna Rao; Shahneen Sandhu; Rebecca Lee; Hanna Eriksson; Marieke van Leeuwen; Kelly M. de Ligt; Alexander Christopher Jonathan van Akkooi; L.V. van de Poll-Franse

doi:10.1016/j.ejca.2024.113601

Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

Mees Egeler
, Julia Lai-Kwon
, Renaud Tissier
, Itske Fraterman
, Anke Kuijpers
, Winan Van Houdt
, Sofie Wilgenhof
, Aparna Rao
, Shahneen Sandhu
, Rebecca Lee
, Hanna Eriksson
, Marieke van Leeuwen
, Kelly M. de Ligt
, Alexander Christopher Jonathan van Akkooi
, L.V. van de Poll-Franse

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	European Journal of Cancer
DOIs	https://doi.org/10.1016/j.ejca.2024.113601
Publication status	Published - Mar 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ejca.2024.113601

Cite this

Egeler, M., Lai-Kwon, J., Tissier, R., Fraterman, I., Kuijpers, A., Houdt, W. V., Wilgenhof, S., Rao, A., Sandhu, S., Lee, R., Eriksson, H., van Leeuwen, M., de Ligt, K. M., van Akkooi, A. C. J., & van de Poll-Franse, L. V. (2024). Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.113601

@article{d7f7887dafdc43feb8052646cd4a9887,

title = "Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy",

author = "Mees Egeler and Julia Lai-Kwon and Renaud Tissier and Itske Fraterman and Anke Kuijpers and Houdt, \{Winan Van\} and Sofie Wilgenhof and Aparna Rao and Shahneen Sandhu and Rebecca Lee and Hanna Eriksson and \{van Leeuwen\}, Marieke and \{de Ligt\}, \{Kelly M.\} and \{van Akkooi\}, \{Alexander Christopher Jonathan\} and \{van de Poll-Franse\}, L.V.",

year = "2024",

month = mar,

doi = "10.1016/j.ejca.2024.113601",

language = "English",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier BV",

}

Egeler, M, Lai-Kwon, J, Tissier, R, Fraterman, I, Kuijpers, A, Houdt, WV, Wilgenhof, S, Rao, A, Sandhu, S, Lee, R, Eriksson, H, van Leeuwen, M, de Ligt, KM, van Akkooi, ACJ & van de Poll-Franse, LV 2024, 'Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy', European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.113601

TY - JOUR

T1 - Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

AU - Egeler, Mees

AU - Lai-Kwon, Julia

AU - Tissier, Renaud

AU - Fraterman, Itske

AU - Kuijpers, Anke

AU - Houdt, Winan Van

AU - Wilgenhof, Sofie

AU - Rao, Aparna

AU - Sandhu, Shahneen

AU - Lee, Rebecca

AU - Eriksson, Hanna

AU - van Leeuwen, Marieke

AU - de Ligt, Kelly M.

AU - van Akkooi, Alexander Christopher Jonathan

AU - van de Poll-Franse, L.V.

PY - 2024/3

Y1 - 2024/3

UR - http://dx.doi.org/10.1016/j.ejca.2024.113601

U2 - 10.1016/j.ejca.2024.113601

DO - 10.1016/j.ejca.2024.113601

M3 - Article

SN - 0959-8049

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

UN SDGs

Access to Document

Other files and links

Cite this